| Literature DB >> 26396738 |
Angela Dramowski1, Mark F Cotton1, Andrew Whitelaw2.
Abstract
INTRODUCTION: In hospital settings, patient isolation is used to limit transmission of certain pathogens (e.g. M. tuberculosis [TB], antibiotic-resistant bacteria and viruses causing respiratory and enteric infection). Data is lacking on utilization of paediatric isolation facilities in low-resource, TB-endemic settings.Entities:
Keywords: Healthcare-associated infection; Infection control; Nosocomial infection; Paediatrics; Patient isolation; Transmission-based precautions; Tuberculosis
Year: 2015 PMID: 26396738 PMCID: PMC4578346 DOI: 10.1186/s13756-015-0078-z
Source DB: PubMed Journal: Antimicrob Resist Infect Control ISSN: 2047-2994 Impact factor: 4.887
Paediatric isolation room utilization
| Variable | Total | Percentage | Interquartile range |
|---|---|---|---|
| Discrete patient isolation episodes | 335 | 100 | - |
| Median patient age (months) | 17 | - | 6–50 |
| Median stay in isolation room (days) | 4 | - | 2–8 |
| Indication for isolation | |||
| - infection control (IPC) purposes | 260 | 78 | |
| - nursing care | 46 | 14 | - |
| - palliation/privacy | 13 | 4 | |
| - othera | 16 | 4 | |
| Transmission-based precautionsb applied | 260 | 100 | |
| - airborne precautions | 136 | 52 | - |
| - droplet precautions | 57 | 22 | |
| - contact precautions | 67 | 26 | |
| Mean | Minimum | Maximum | |
| Isolation room occupancy ratec | 2172/3294 | 225/540 | 487/558 |
| (66 %) | (42 %) | (87 %) |
IPC = infection prevention and control
aother = no obvious reason for isolation (n = 11), behavioural isolation (n = 3), protective isolation (n = 2)
bUsing the 2007 CDC isolation guidelines[1]
cCalculated as the sum of days when isolation rooms (n = 18) were occupied divided by [total isolation bed capacity x number of days in the observation period] i.e. 6 months to calculate mean or 1 month to calculate minimum and maximum occupancy rates
Microbiological isolatesa from patients in isolation for IPC purposes
| Category | Variable | Total (%) |
|---|---|---|
| All suspected TB ( | pulmonary TB | 118 (91) |
| extra-pulmonary TBb | 12 (9) | |
| TB smear microscopy ( | not tested (diagnosis confirmed at referral hospital) | 10 (8) |
| smear-negative | 108 (83) | |
| smear-positive (1–10 AFB/field) | 8 (6) | |
| smear-positive (11–99 AFB/field) | 4 (3) | |
| Confirmed TBc ( | TB diagnosis confirmed at referral hospital | 10 |
| GeneXpert positive | 43 | |
| TB culture positive | 45 | |
| Drug-susceptibility profile of culture positive cases ( | Drug-susceptible (DS) | 33 (74) |
| Multidrug-resistant (MDR) | 9 (20) | |
| Rifampicin mono-resistant (RMR) | 2 (4) | |
| Extensively drug-resistant (XDR) | 1 (2) | |
| Total (number DR) | ||
| All abacterial/fungal isolates cultured from patients in isolation ( | Gram positives | |
|
| 7 (2) | |
| Other gram positivesd | 4 | |
| Gram negatives: Enterobacteriaceae | ||
|
| 11 (10) | |
|
| 5 (1) | |
|
| 4 (2) | |
| Other Enterobacteriaceaee | 4 | |
| Gram negatives: Non-fermenters | ||
|
| 4 (4) | |
|
| 5 (3) | |
| Others | ||
|
| 2 | |
|
| 1 | |
|
| 2 | |
| Viral pathogens confirmed among patients in isolation ( | Gastrointestinal viruses | |
| Hepatitis A | 6 | |
| Rotavirus | 4 | |
| Enteric adenovirus | 2 | |
| Respiratory viruses | ||
| Respiratory syncytial virus | 15 | |
| Adenovirus | 12 | |
| Rhinovirus | 4 | |
| Parainfluenza virus | 2 | |
| Other respiratory virusesf | 3 | |
| Other | ||
| Varicella | 2 | |
| Rubella | 1 | |
aSome patients were isolated on clinical suspicion of sepsis or suspicion of a pathogen warranting isolation, but laboratory tests subsequently confirmed a pathogen which did not warrant isolation or transmission-based precautions by CDC guidelines[1] e.g. Candida albicans; TB = tuberculosis
bExtra-pulmonary TB: disseminated (7), TB lymphadenitis (3), TB meningitis (2)
cconfirmed TB = geneXpert positive or culture positive for mTB; DR = drug-resistant
dOther gram positives: C. difficile (1), S. pyogenes (1), S. pneumoniae (1), E. faecium (1)
eOther Enterobacteriaceae: S. typhi (1), S. non-typhi (1), C. freundii (1), P. mirabilis (1)
Other respiratory virusesf: Influenza virus (1), Bocavirus (1), Human metapneumovirus (1)
Missed opportunitiesa for patient isolation (May – October 2014)
| Pathogen type and species | Missed isolation (Non-isolated patients with pathogens warranting isolation) | ||||||
|---|---|---|---|---|---|---|---|
| May | June | July | August | Sept. | Oct. | Study period | |
| bMDR bacteria | |||||||
| Methicillin-resistant | 3 | 0 | 0 | 1 | 2 | 1 | 7 |
| Carbapenem-resistant | 0 | 1 | 0 | 0 | 0 | 2 | 3 |
| MDR | 0 | 0 | 0 | 1 | 2 | 1 | 4 |
| Extended spectrum B-lactamase producing (ESBL) Enterobacteriaceae | 8 | 8 | 5 | 4 | 1 | 3 | 29 |
|
c
| |||||||
| Drug-susceptible (DS) | 2 | 0 | 3 | 3 | 3 | 5 | 16 |
| Drug-resistant (DR) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Enteric viruses | |||||||
| Hepatitis A | 3 | 4 | 5 | 7 | 2 | 2 | 23 |
| Rotavirus and/or enteric Adenovirus | 0 | 2 | 2 | 1 | 0 | 0 | 5 |
| Respiratory viruses | |||||||
| Respiratory syncytial virus A/B | 9 | 5 | 2 | 2 | 0 | 1 | 19 |
| Adenovirus | 2 | 2 | 3 | 3 | 3 | 1 | 14 |
| dOther respiratory viruses | 0 | 3 | 4 | 2 | 2 | 4 | 15 |
| Missed patient isolation episodesa | 27 | 25 | 24 | 24 | 15 | 20 | 135 |
| Inappropriate isolation room use (days)e | 29 | 77 | 7 | 30 | 27 | 1 | 171 |
Missed patient isolation opportunities = patients with pathogens warranting isolation that were not isolated plus days of delay in patients with delayed isolation; multiple laboratory isolates of the same pathogen from 1/more sites was considered a single infection episode warranting patient isolation
bMultidrug-resistant (MDR) bacteria isolated from a clinical specimen (blood culture, urine, tissue, pus, wound swab, catheter tip) as per proposed definitions [12] (including methicillin-resistant S. aureus [MRSA], carbapenem-resistant A. baumanni [CRAB], MDR P. aeruginosa [MDR PA] and extended spectrum B-lactamase producing Enterobacteriaceae [ESBL])
c M. tuberculosis (M.tb) = any form of drug-susceptible (DS) or drug-resistant (DR) M.tb isolated on GeneXpert, smear microscopy or TB culture; Viruses included gastrointestinal and respiratory pathogens identified by rapid assays, ELISA or PCR panels
dOther respiratory viruses warranting isolation and transmission-based precautions = human rhinovirus, parainfluenza 1/2/3, Influenza A/B and human metapneumovirus
Inappropriate isolation room use = total days when isolation rooms were used for inappropriate purposes i.e. without a clinical indication, failure to de-isolate after laboratory testing identified no pathogens or pathogens that did not warrant isolation
Fig. 1Projected demand for paediatric isolation facilities (May – October 2014). Occupied bed-days = the cumulative daily occupancy of the 18 isolation beds per month; missed bed-days = duration of hospitalization of patients with pathogens warranting isolation that were not isolated plus days of delay in patients with late implementation of isolation precautions; estimated syndromic bed-day requirement = number of patients with clinical suspicion of viral illness but a negative laboratory test/s for viral pathogens (measured as empiric isolation required from day of admission to a negative test result); projected occupancy = sum of occupied bed-days plus missed bed-days plus estimated syndromic days, minus total bed-days of inappropriate use; Bed-days of inappropriate isolation room use (not shown in figure) = total days per period where isolation rooms were used for inappropriate purposes i.e. where there was no clinical indication for isolation or where a patient was not de-isolated after laboratory testing identified no pathogens or pathogens that did not warrant isolation